Terns Pharmaceuticals, Inc.
Clinical-stage biopharma developing small-molecule drugs for oncology and obesity.
TERN | US
Overview
Corporate Details
- ISIN(s):
- US8808811074
- LEI:
- Country:
- United States of America
- Address:
- 1065 EAST HILLSDALE BLVD., SUITE 100, 94404 FOSTER CITY
- Website:
- https://ternspharma.com/
Description
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that develops a portfolio of small-molecule product candidates for serious diseases, with a focus on oncology and obesity. The company's strategy is to innovate upon de-risked, clinically validated mechanisms of action to create therapies with superior efficacy, safety, and convenience profiles. Its lead product candidate, TERN-701, is an oral, allosteric BCR-ABL inhibitor in development for the treatment of chronic myeloid leukemia (CML). Terns aims to address significant unmet medical needs by improving upon existing treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Terns Pharmaceuticals, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Terns Pharmaceuticals, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Terns Pharmaceuticals, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
